Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pitambar Prusty

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archives of Internal Medicine|December 15, 2004
Good and bad dying: armed forces physician perspectivesKuldip Anand, Ajit Kashyap, Pitambar Prusty
Indian Journal of Endocrinology and Metabolism|November 20, 2013
Resistant prolactinoma: Is it monoclonal or polyclonal?K V S Hari Kumar, Pitambar Prusty
Diabetes Research and Clinical Practice|March 16, 2013
Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label studyK V S Hari Kumar, Altamash Shaikh, Pitambar Prusty
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 22, 2011
Diabetes in young--unusual case presentationK V S Hari Kumar, Sai Priya, Altamash Shaikh, et al.
Indian Journal of Endocrinology and Metabolism|January 10, 2014
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the East India cohort of the A1chieve studyAbhay Kumar Sahoo, Sambit Das, Pitambar Prusty, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archives of Internal Medicine|December 15, 2004
Good and bad dying: armed forces physician perspectivesKuldip Anand, Ajit Kashyap, Pitambar Prusty
Indian Journal of Endocrinology and Metabolism|November 20, 2013
Resistant prolactinoma: Is it monoclonal or polyclonal?K V S Hari Kumar, Pitambar Prusty
Diabetes Research and Clinical Practice|March 16, 2013
Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label studyK V S Hari Kumar, Altamash Shaikh, Pitambar Prusty
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 22, 2011
Diabetes in young--unusual case presentationK V S Hari Kumar, Sai Priya, Altamash Shaikh, et al.
Indian Journal of Endocrinology and Metabolism|January 10, 2014
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the East India cohort of the A1chieve studyAbhay Kumar Sahoo, Sambit Das, Pitambar Prusty, et al.
Pageof 1